Correlation of peripheral arterial blood flow with plasma chemerin and VEGF in diabetic peripheral vascular disease
Abstract
Aims: Progressive vasodegeneration in microvascular beds is the major underlying factor in initiation and progression of diabetic complications. Chemerin shows a strong correlation with various facets of the metabolic syndrome, which is associated with dysregulated angiogenesis. VEGF is shown to have an angiogenic role in certain cardiovascular risk factors, including diabetes. Ankle/brachial index is a known approach for assessing lower-limb peripheral vascular disease. This study aimed to elucidate the correlation of ankle/brachial index as a marker of peripheral blood flow with biomarkers of angiogenesis, plasma chemerin and VEGF, in diabetic peripheral vascular disease. Materials & methods: Ninety age- and sex-matched females were enrolled in the study: 30 were controls, while 60 had Type 2 diabetes, of whom 30 had controlled diabetes (group II) and 30 had diabetes with peripheral vascular disease (group III) diagnosed by an abnormal ankle/brachial index. Plasma levels of chemerin and VEGF were measured. Results: There was a significant decrease of the ankle/brachial index and significant increase in plasma chemerin and VEGF in diabetic patients with peripheral vascular disease (p < 0.05). A positive correlation was observed between ankle/brachial index, plasma chemerin and VEGF in diabetic patients with peripheral vascular disease. Linear regression analysis revealed that neither chemerin nor VEGF were predictors for ankle/brachial index in diabetic peripheral vascular disease. Conclusion: This study elucidates, for the first time, the rise of plasma levels of chemerin and VEGF, and their positive correlation with ankle/brachial index in diabetic peripheral vascular disease. These findings denote their angiogenic effect of improving the peripheral blood flow in diabetic peripheral vascular disease. Further studies are warranted to examine the exact role of these two biomarkers in diabetic vasculopathy.
Papers of special note have been highlighted as: ▪▪ of considerable interest
References
- 1 Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC. Effects of gliclazide on endothelial function in patients with newly diagnosed Type 2 diabetes. Eur. J. Pharmacol.659(2–3),296–301 (2011).
- 2 Dobarro D, Gómez-Rubín MC, Sanchez-Recalde A et al. Current pharmacological approach to restore endothelial dysfunction. Cardiovasc. Hematol. Agents Med. Chem.7(3),212–222 (2009).
- 3 Jennifer LH, Christian MM, Xiaohong WH. Gibbons hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. Circulation Res.87,574 (2000).
- 4 Yu T, Sheu SS, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res.79(2),341–351 (2008).
- 5 Fatehi-Hassanabad Z, Chan CB, Furman BL. Reactive oxygen species and endothelial function in diabetes. Eur. J. Pharmacol.636(1–3),8–17 (2010).
- 6 Bozaoglu K, Curran JE, Stocker CJ et al. Chemerin, a novel adipokine in the regulation of angiogenesis. J. Clin. Endocrinol. Metab.95(5),2476–2485 (2010).
- 7 Yamamoto T, Qureshi AR, Anderstam B et al. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol. Dial. Transplant.25(12),4017–4023 (2010).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 8 Yang M, Yang G, Dong J et al. Elevated plasma levels of chemerin in newly diagnosed Type 2 diabetes mellitus with hypertension. J. Invest. Med.58(7),883–886 (2010).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 9 Klöting N, Fasshauer M, Dietrich A et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab.299(3),E506–E515 (2010).
- 10 Bosch-Marcé M, Pola R, Wecker AB et al. Hyperhomocysteinemia impairs angiogenesis in a murine model of limb ischemia. Vasc. Med.10(1),15–22 (2005).
- 11 Quattrini C, Jeziorska M, Boulton AJ, Malik RA. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fibre loss in human diabetic neuropathy. Diabet. Care31(1),140–145 (2008).
- 12 Kirchmair R, Tietz AB, Panagiotou E et al. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. Mol. Ther.15(1),69–75 (2007).
- 13 Dong X, Wang YS, Dou GR et al. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLoS ONE6(4),e18481 (2011).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 14 Purroy F, Coll B, Oró M et al. Predictive value of ankle brachial index in patients with acute ischaemic stroke. Eur. J. Neurol.17(4),602–606 (2009).
- 15 Fowkes FG, Price JF, Stewart MC et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA303(9),841–848 (2010).
- 16 Varley H. Practical Clinical Biochemistry (6th Edition). Heinemann Medical Books, London, UK (1998).
- 17 Burtis CA, Ashwood ER. Teitz Textbook of Clinical Chemistry (2nd Edition). WB Saunders Company, PA, USA (1994).
- 18 Zakareia FA, Al-Drees AA, Al-Regaiy KA, Alrouq FA. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, fatty acid synthase and adrenomedullin in diabetic retinopathy. J. Diabet. Complicat.24(3),179–185 (2010).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 19 Michael L, Alexander B, Martin G et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol.161(2),339–344 (2009).
- 20 Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commun.391(4),1762–1768 (2010).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 21 Mahdy RA, Nada WM. Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy. Ophthalmic Res.45(2),87–91 (2011).
- 22 Wirostko B, Wong TY, Simó R. Vascular endothelial growth factor and diabetic complications. Progress Retinal Eye Res.27(6),608–621 (2008).
- 23 Kolostova K, Taltynov O, Pinterova D et al. Wound healing gene therapy: cartilage regeneration induced by vascular endothelial growth factor plasmid. Am. J. Otolaryngol.33(1),68–74 (2011).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
- 24 Saito D, Maeshima Y, Nasu T et al. Amelioration of renal alterations in obese Type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am. J. Physiol. Renal. Physiol.300(4),F873–F886 (2011).▪▪ Discusses the recent roles of chemerin and VEGF in angiogenesis in diabetes and its complications.
